Manufacturing and marketing testosterone replacement therapy (TRT) drugs is a huge industry. According to data presented by Statistica, testosterone replacement hormone products brought in over $2.4 billion in 2013. That number has risen in years, recently topping $3.8 billion. The problem is there is not much evidence about what it…
Litigating a testosterone replacement therapy lawsuit in Boston can involve many complex issues. One recently litigated issues deals with the challenges in filing certain claims against generic drug manufacturers involving failure to warn of a known danger. This is a claim that the manufacturer of a drug did not adequately…
The Journal of the American Medical Association (JAMA) recently published a large series of studies that primarily involved the risks and benefits of testosterone replacement therapy. A recent article from Star-Telegram examined the results of these and discussed what they mean to those who are considering taking testosterone replacement therapy…
A federal judge in Illinois is overseeing a multi-district litigation action against the maker of testosterone replacement therapy drugs, with plaintiffs alleging the treatment caused them to suffer heart ailments. The litigation has been ongoing for some time – and is still not at the trial phase. The MDL represents…